Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FXANL
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ABBV-637
|
|||||
| Synonyms |
ABBV-637; ABBV 637; ABBV637
Click to Show/Hide
|
|||||
| Organization |
AbbVie, Inc.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
BCL-XL inhibitor
|
Payload Info | ||||
| Therapeutic Target |
Bcl-2-like protein 1 (BCL2L1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
